Risk factors for linezolid-associated thrombocytopenia in adult patients
Authors:
Open Access
- 14 August 2014
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 42 (6) , 1007-1012
Abstract
Thrombocytopenia (TP) is a common adverse effect of linezolid (LZD). However, risk factors for LZD-associated TP have been reported in Western patients with relatively heavy body weight. The aim of this study was to determine the risk factors for LZD-associated TP in Asian population.Keywords
This publication has 36 references indexed in Scilit:
- Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literatureEuropean Journal of Clinical Pharmacology, 2013
- Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled StudyClinical Infectious Diseases, 2012
- Population Pharmacokinetic and Pharmacodynamic Analysis of Linezolid and a Hematologic Side Effect, Thrombocytopenia, in Japanese PatientsAntimicrobial Agents and Chemotherapy, 2011
- Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunctionInternational Journal of Antimicrobial Agents, 2010
- Population Pharmacokinetics of Linezolid in Adults with Pulmonary TuberculosisAntimicrobial Agents and Chemotherapy, 2009
- Renal function as a predictor of linezolid-induced thrombocytopeniaInternational Journal of Antimicrobial Agents, 2009
- High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiencyInternational Journal of Antimicrobial Agents, 2006
- Linezolid pharmacokinetics in pediatric patients: an overviewThe Pediatric Infectious Disease Journal, 2003
- Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.2001